Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention

Published:2016-01-19 Issue:3 Volume:133 Page:248-255
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

O’Donoghue Michelle L.¹,Bhatt Deepak L.¹,Stone Gregg W.¹,Steg Ph. Gabriel¹,Gibson C. Michael¹,Hamm Christian W.¹,Price Matthew J.¹,Prats Jayne¹,Liu Tiepu¹,Deliargyris Efthymios N.¹,Mahaffey Kenneth W.¹,White Harvey D.¹,Harrington Robert A.¹

Affiliation:

1. From Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA (M.L.O., D.L.B.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S.); FACT, DHU FIRE, Université Paris-Diderot, Sorbonne Paris-Cité, France (G.S.); LVTS INSERM U-1148, Hôpital Bichat, HUPNVS, AP-HP, Paris, France (G.S.); NHLI, Imperial College, Royal Brompton Hospital, London, United Kingdom (G.S.); Beth Israel Deaconess Medical Center, Division of Cardiology, Boston, MA (C.M.G.);...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Enrollment of Women in National Heart, Lung, and Blood Institute-Funded Cardiovascular Randomized Controlled Trials Fails to Meet Current Federal Mandates for Inclusion

2. Representation of Women in Randomized Clinical Trials of Cardiovascular Disease Prevention

3. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

4. Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors

5. Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome?;Frontiers in Cardiovascular Medicine;2022-10-31

2. Sex Differences in Platelet Reactivity in Patients With ST-Elevation Myocardial Infarction: A Sub-Analysis of the ON-TIME 3 Trial;Frontiers in Cardiovascular Medicine;2021-10-04

3. Cardiovascular Medications;Sex Differences in Cardiac Diseases;2021

4. Interventions in Ischemic Heart Disease;Sex Differences in Cardiac Diseases;2021

5. How personalized are benefit and harm results of randomized trials? A systematic review;Journal of Clinical Epidemiology;2020-10